Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Florida

University of Florida in Gainesville, Florida, United States is listed as a site for 1,313 registered clinical trials, 322 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,313
Ongoing 322

This page covers the site record University of Florida in Gainesville, Florida, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, University of Florida, also sponsors trials.

Get the University of Florida report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,313 trials counted.

  • Phase 1 70 trials
  • Phase 1/2 71 trials
  • Phase 2 252 trials
  • Phase 2/3 23 trials
  • Phase 3 212 trials
  • Phase 4 52 trials
  • Not applicable 376 trials
  • Observational 246 trials
  • Expanded access 11 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 323 trials
  • Completed 781 trials
  • Terminated 168 trials
  • Other 41 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access)

Top of scale: 85

1996: 2 trials (Phase 3 1, Phase 2 1) 1997: 4 trials (Observational 1, Not applicable 1, Phase 4 1, Phase 3 1) 1998: 1 trials (Phase 2 1) 1999: 3 trials (Not applicable 2, Phase 1/2 1) 2000: 4 trials (Phase 4 1, Phase 3 2, Phase 2/3 1) 2001: 5 trials (Observational 1, Not applicable 2, Phase 3 1, Phase 2 1) 2002: 15 trials (Observational 4, Phase 4 1, Phase 3 7, Phase 2 3) 2003: 10 trials (Observational 2, Not applicable 4, Phase 3 3, Phase 2/3 1) 2004: 19 trials (Observational 3, Not applicable 4, Phase 4 2, Phase 3 5, Phase 2 3, Phase 1/2 1, Phase 1 1) 2005: 27 trials (Observational 2, Not applicable 7, Phase 3 9, Phase 2 4, Phase 1/2 2, Phase 1 3) 2006: 31 trials (Observational 6, Not applicable 6, Phase 4 1, Phase 3 11, Phase 2/3 2, Phase 2 3, Phase 1/2 1, Phase 1 1) 2007: 34 trials (Observational 6, Not applicable 6, Phase 4 1, Phase 3 9, Phase 2/3 2, Phase 2 6, Phase 1/2 3, Phase 1 1) 2008: 40 trials (Observational 6, Not applicable 7, Phase 4 6, Phase 3 9, Phase 2 7, Phase 1/2 2, Phase 1 3) 2009: 35 trials (Observational 2, Not applicable 8, Phase 4 1, Phase 3 11, Phase 2 9, Phase 1/2 2, Phase 1 2) 2010: 56 trials (Observational 11, Not applicable 7, Phase 4 2, Phase 3 9, Phase 2/3 1, Phase 2 19, Phase 1/2 4, Phase 1 3) 2011: 32 trials (Observational 8, Not applicable 10, Phase 4 1, Phase 3 5, Phase 2 7, Phase 1/2 1) 2012: 43 trials (Other 1, Observational 7, Not applicable 13, Phase 3 12, Phase 2 7, Phase 1 3) 2013: 65 trials (Observational 19, Not applicable 18, Phase 3 10, Phase 2/3 3, Phase 2 8, Phase 1/2 2, Phase 1 5) 2014: 60 trials (Observational 16, Not applicable 20, Phase 4 2, Phase 3 6, Phase 2 10, Phase 1/2 5, Phase 1 1) 2015: 56 trials (Observational 22, Not applicable 14, Phase 4 1, Phase 3 5, Phase 2 7, Phase 1/2 4, Phase 1 3) 2016: 72 trials (Observational 16, Not applicable 13, Phase 4 3, Phase 3 8, Phase 2/3 1, Phase 2 21, Phase 1/2 6, Phase 1 4) 2017: 85 trials (Observational 18, Not applicable 27, Phase 4 4, Phase 3 6, Phase 2/3 3, Phase 2 17, Phase 1/2 6, Phase 1 4) 2018: 72 trials (Observational 7, Not applicable 23, Phase 4 7, Phase 3 12, Phase 2 15, Phase 1/2 4, Phase 1 4) 2019: 71 trials (Observational 24, Not applicable 21, Phase 4 2, Phase 3 8, Phase 2/3 1, Phase 2 10, Phase 1/2 3, Phase 1 2) 2020: 64 trials (Observational 9, Not applicable 20, Phase 4 4, Phase 3 9, Phase 2/3 2, Phase 2 12, Phase 1/2 2, Phase 1 6) 2021: 82 trials (Observational 11, Not applicable 25, Phase 4 4, Phase 3 13, Phase 2/3 2, Phase 2 17, Phase 1/2 4, Phase 1 6) 2022: 78 trials (Observational 10, Not applicable 29, Phase 4 4, Phase 3 7, Phase 2/3 2, Phase 2 19, Phase 1/2 3, Phase 1 4) 2023: 62 trials (Observational 9, Not applicable 15, Phase 4 1, Phase 3 12, Phase 2/3 2, Phase 2 14, Phase 1/2 4, Phase 1 5) 2024: 62 trials (Observational 14, Not applicable 22, Phase 4 1, Phase 3 7, Phase 2 12, Phase 1/2 4, Phase 1 2) 2025: 56 trials (Observational 8, Not applicable 24, Phase 4 2, Phase 3 8, Phase 2 8, Phase 1/2 3, Phase 1 3)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 52
2025 56
2024 62
2023 62
2022 78
2021 82
2020 64
2019 71
2018 72
2017 85

Showing 10 of 31 years.

Start your 14-day trial Email me all 31 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,313 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 291 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 589 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF